Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof

Details for Australian Patent Application No. 2002246738 (hide)

Owner BIO-TECHNOLOGY GENERAL CORP.

Inventors Nimrod, Abraham; Levanon, Avigdor; Amit, Boaz; Plaksin, Daniel; Szanthon, Ester; Hagai, Yocheved; Lazarovits, Janette; Kooperman, Lena; Richter, Tamar; Vogel, Tikva; Peretz, Tuvia; Mar-Haim, Hagit

Agent Shelston IP

Pub. Number AU-A-2002246738

PCT Pub. Number WO2002/053700

Priority 60/258,948 29.12.00 US; 09/751,181 29.12.00 US

Filing date 31 December 2001

Wipo publication date 16 July 2002

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002246738

4 December 2003 Change of Name(s) of Applicant(s), Section 104

  Bio-Technology General Corp. The name of the applicant has been changed to Savient Pharmaceuticals, Inc. Change of Name(s) of Applicant(s), Section 104

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246739-MELT POLYCARBONATE CATALYST SYSTEMS

2002246737-Specific human antibodies for selective cancer therapy